An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy

Information on longer-term safety and tolerability is needed to confidently prescribe alefacept therapy for chronic plaque psoriasis beyond 1 or 2 courses. The aim of this work was to further examine the safety profile of alefacept by integrating data from clinical trials involving patients with chr...

Ausführliche Beschreibung